n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine has been researched along with scriptaid in 1 studies
Studies (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Trials (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Recent Studies (post-2010) (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Studies (scriptaid) | Trials (scriptaid) | Recent Studies (post-2010) (scriptaid) |
---|---|---|---|---|---|
79 | 1 | 16 | 101 | 1 | 73 |
Protein | Taxonomy | n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine (IC50) | scriptaid (IC50) |
---|---|---|---|
Histone deacetylase 8 | Schistosoma mansoni | 1.77 | |
Histone deacetylase 3 | Homo sapiens (human) | 0.3274 | |
Leukotriene A-4 hydrolase | Homo sapiens (human) | 4.4 | |
Histone deacetylase 4 | Homo sapiens (human) | 0.43 | |
Histone deacetylase 1 | Homo sapiens (human) | 0.8318 | |
Histone deacetylase 7 | Homo sapiens (human) | 1.33 | |
Histone deacetylase 2 | Homo sapiens (human) | 0.63 | |
Polyamine deacetylase HDAC10 | Homo sapiens (human) | 0.43 | |
Histone deacetylase 11 | Homo sapiens (human) | 2.83 | |
Histone deacetylase 8 | Homo sapiens (human) | 2.038 | |
Histone deacetylase 6 | Homo sapiens (human) | 0.1194 | |
Histone deacetylase 9 | Homo sapiens (human) | 0.63 | |
Histone deacetylase 5 | Homo sapiens (human) | 0.43 | |
Nuclear receptor corepressor 2 | Homo sapiens (human) | 0.1884 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
1 other study(ies) available for n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and scriptaid
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |